Insights and commentary from our University experts, thought leaders, and graduate students on pharmaceutical, science, healthcare, and educational topics.

05/16/2016

USciences team to be honored at American Heart Association’s Heartsaver Awards

The New Jersey American Heart Association will recognize University of the Sciences’ CPR Leadership Team for going above and beyond basic CPR curriculum requirement at an award ceremony on June 1. The Heartsaver Awards, held at the Robert Wood Johnson Hamilton Center for Health and Wellness in Hamilton, NJ, honor individuals who made a rescue effort to save the life of an individual experiencing a cardiac emergency or any organization or business that takes extraordinary steps to strengthen the American Heart Association Chain of Survival. The Chain of Survival is five steps crucial to someone experiencing a cardiac arrest, heart...

Continue reading "USciences team to be honored at American Heart Association’s Heartsaver Awards " »

Kayla Askey PharmD’20 awarded for research into plant extract’s toxicity to breast cancer cells

Kayla Askey PharmD’20 won first prize in the PharmD category last month at Thomas Jefferson University’s Sigma Xi Student Research Day for her research on a South African medicinal plant which contains extracts that are selectively toxic to breast cancer cells, while leaving healthy cells unaffected. Askey’s research poster, presented at the April 13 event, outlined research into the use of extracts from a medicinal plant called Myrothamnus flabellifolius, which induced apoptosis of breast cancer cells. The extract causes the Triple Negative Breast Cancer (TNBC) cells to die within 72 hours after treatment without affecting the normal breast cells, according...

Continue reading "Kayla Askey PharmD’20 awarded for research into plant extract’s toxicity to breast cancer cells" »

05/10/2016

What is Big Data and how will it revolutionize the health industry? Part III

Big Data has already made an impact in many industries, and is transforming how we think of healthcare and public health. It will continue to revolutionize healthcare, pharmaceuticals, clinical trial management, administration, and all aspects of the health industry. The US has the highest healthcare costs in the world, and our outcomes are often mediocre. The application of Big Data techniques will help reduce these costs and improve outcomes. As the field matures, we will see a cumulative effect, as insights build atop each other. Big Data is a revolution, but it is still in its infancy. The truth is,...

Continue reading "What is Big Data and how will it revolutionize the health industry? Part III" »

05/05/2016

The European Biosimilars Market

In previous blogs, I have written about what biosimilars are and have speculated about the development of the US biosimilars industry. While the US biosimilars market may not fully mature for another decade, the European biosimilars market has been expanding for years. In this blog, I will analyze what the European biosimilars market looks like and whether it is a preview of the US biosimilars market. The biosimilars market in Europe has existed now for over a decade. The first approved biosimilar was a somatotropin in 2006. Since then, Europe has seen 22 biosimilars emerge in several different drug classes...

Continue reading "The European Biosimilars Market" »

04/29/2016

What is Big Data and how will it revolutionize the health industry? Part II

Big Data is poised to revolutionize the healthcare industry. The revolution goes beyond just analyzing text based notes. It is being used in predictive analytics, prescriptive analytics, genomics, and in many other ways. You may have heard the term “Internet of Things.” This refers to the fact that many devices are now connected to the Internet, from your phone to your car to wearables like the Apple Watch and FitBit. It is estimated that by 2020, there will be 25 billion connected devices. These devices capture real time data, and allow for real-time alerts. They produce tons of data on...

Continue reading "What is Big Data and how will it revolutionize the health industry? Part II" »

04/28/2016

The Reference Product Strikes Back

A lot of consideration has gone into biosimilars and what they mean for the biologics drug market. The idea behind biosimilars is that they will reduce costs by providing cheaper alternatives to existing biologic drugs. As mentioned in previous blogs however, biosimilars are by no means a cheap and simple cure to high drug costs. There are several road blocks like high production costs and long periods of development biosimilars must face on the way to the market place. These road blocks cut into the discounts biosimilars could offer. This leaves a unique opening for reference products. Reference products could...

Continue reading "The Reference Product Strikes Back" »

04/25/2016

More Faculty, Staff, Student and Alumni Achievements

Student Mathematics Papers Presented at Section Meeting Faculty sponsor and Professor of Mathematics Dr. Salar Alsardary led a group of USciences students to present papers at the Eastern Pennsylvania and Delaware Section of the Mathematical Association of America at Muhlenberg College on April 2, 2016. The undergraduates presented on three topics. The History of Algorithms: Deion Floyd PhC’17, Eli Halpern C’17 Sudoko: Matt Marshall BI’19, Tori Lugiano C’19 The History of Knight's Tour: Brianna Mengini PharmD’20, Brielle Okulicz PharmD’20, Jaden Daubert PharmD’20 Student Life’s Deena Smith, a Residence Director for Goodman and Wilson Halls, was recently accepted into the Regional...

Continue reading "More Faculty, Staff, Student and Alumni Achievements" »

04/21/2016

Biosimilars and P&T Committees

Imagine that you are on an APPE rotation at a local managed care organization (MCOs) and your preceptor asks you to research a medication that is being considered on the Pharmacy and Therapeutics Committee (P&T Committee). Because P&T Committees are inter-professional committees designed to consider whether to add a new medication to a formulary, you as a student pharmacist are expected to find information to help make that decision. Since pharmacists are expected to speak the language of business and science, your research must cover a broad area. As you begin to research the medication, you notice that it is...

Continue reading "Biosimilars and P&T Committees " »

04/18/2016

PCP Students Among Hundreds of Pharmacists Who Gathered in PA Capitol as “Now Is The Time...”

On Wednesday, April 6, hundreds of pharmacists and student pharmacists converged at the Capitol in Harrisburg for Pennsylvania Pharmacy Day to push the theme of "NOW is the time...” The theme specifically selected to mean the time for pharmacy benefit manager (PBM), for advancing the role of pharmacists' in healthcare, and for protecting patient care. The event was sponsored by the Pennsylvania Pharmacists Association (PPA). Pharmacists and student pharmacists held over 160 appointments to meet with legislators throughout the day, along with a press conference and rally in the Main Rotunda at the Capitol. The rally focused on key legislative...

Continue reading "PCP Students Among Hundreds of Pharmacists Who Gathered in PA Capitol as “Now Is The Time...”" »

Public Perceptions of Moral Insanity in the 19th Century

Dr. Cristina Hanganu-Bresch, assistant director in the Writing Programs, was invited to present at the “Histories of Forensic Psychiatry and Forensic Psychology” conference held March 17-18, 2016, at University of Canterbury in New Zealand, thanks to a travel grant offered by the conference organizers. Put together by Dr. Heather Wolffram, the conference included a small group of international scholars from Spain, Germany, Hungary, the United States, Australia and New Zealand, and aimed to shed light on the intersection between the two disciplines. The conference program stated: “The intersection of the human sciences with the law has been an area of...

Continue reading "Public Perceptions of Moral Insanity in the 19th Century" »

My Photo


USciences Experts Guide
A listing of faculty members and their areas of expertise for the media

© 2011 University of the Sciences in Philadelphia • 600 South 43rd Street • Philadelphia, PA 19104 • 215.596.8800